LAUSR

Objective: Health-related quality of life (HRQoL) is a key patient-reported outcome in care and research. The few instruments that assess the HRQoL of parents and partners of people with type 1 diabetes (T1D) emphasize caregiving burden or are usually proxy measures (reporting on behalf of person with T1D). We created measures assessing parents’ and partners’ own HRQoL as part of a larger study to develop and validate a suite of instruments to measure HRQoL in children through older adults with T1D. Methods: Qualitative interviews (n=81 people with T1D and parents/partners, 8 providers) identified HRQoL themes to include. Drafts were piloted with n=41. Resulting measures were validated with n=644 parents and n=186 partners from 6 T1D Exchange sites across the U.S., including the HRQoL measure (2 times, approx. 3 months apart), measures of relevant constructs (SF-12, Satisfaction with Life Scale, Diabetes Family Impact Scale, Partner Diabetes Distress Scale), and medical chart-confirmed HbA1c. We report exploratory factor analyses (Promax rotation) and psychometric data for the 4 parent measures (child age Results: Each measure had a unique set of 21-30 positive and negative items loading on 3-4 scales. Reliability was good: total score α range=0.80-0.88, test-retest r range=0.75-0.86. Significant correlations between the total HRQoL scores and measures of general quality of life (r=0.30-0.53), mental well-being (r=0.37-0.53), T1D family impact (parents of youth, r=-0.64--0.72), and diabetes distress (parents/partners of adults, r=-0.76--0.75) indicated construct validity. Scores were not correlated with HbA1c. Conclusions: The new measures of T1D-specific HRQoL in parents and partners have relevant items and factors, and demonstrate strong psychometric properties. These innovative tools will permit assessment of the experiences of parents and partners of people with T1D for use in research and practice. Disclosure M.E. Hilliard: None. C.G. Minard: None. D.G. Marrero: None. M. de Wit: Research Support; Self; Sanofi. D. Thompson: None. A. Verdejo: None. B. Anderson: None. Funding The Leona M. and Harry B. Helmsley Charitable Trust (2015PG-T1D084)